|
House Singles Out OGD Funding in Proposed 2013 Spending Bill
The House version of the FDA’s fiscal 2013 spending bill mandates the agency provide the Office of Generic Drugs $52.5 million next year.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
Bill Requiring Generic Opioid Makers to Mimic Abuse-Deterrent Features Reintroduced in HouseGPhA Says State Biosimilars Substitution Laws Could Have ‘Chilling Effect,’ Innovators DisagreeLegislators Press FDA on Safety of Opioid GenericsMembers of Congress Press FDA on Safety of Non-Tamper Resistant Opioid Generics
|
Subscribe
Archives